Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminum cation is the trivalent form of aluminum (Al^3+) and serves as the active ionic species in various pharmaceutical and industrial compounds. In medicine, it is most commonly encountered as a component of antacids (such as aluminum hydroxide) and topical astringents (such as Burow's solution, which contains aluminum acetate). The primary mechanism of action involves its ability to neutralize gastric acid when used orally or to act as an astringent by precipitating proteins on skin or mucosal surfaces when applied topically. Aluminum cation can also bind phosphate in the gastrointestinal tract, reducing serum phosphate levels in patients with hyperphosphatemia. It has antibacterial properties due to its ability to damage bacterial cell walls[1][2][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aluminum cation.